Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.

Gorlin Syndrome Alliance Regional Meeting – Washington, DC

January 22, 2020

Washington, DC
June 20, 2020
Details TBD

Palvella Therapeutics Announces Series D Financing of Up…

January 5, 2023

Led by new investor Petrichor, with participation from new and existing investors Lead product candidate

Palvella Therapeutics Announces Pipeline Update on QTORIN™ 3.9%…

February 21, 2023

Pivotal Phase 3 data for the treatment of Pachyonychia Congenita anticipated mid-2023 Phase 2 data…